This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jun. 12, 2013


 



LIVESTRONG Foundation seeks to automate cancer tool
iHealthBeat
The LIVESTRONG Foundation has released a report that shows high user satisfaction with an online tool to help cancer survivors receive post-treatment care plans, and the foundation is launching a study into whether electronic health record data can help streamline the tool.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement


Weekly chemo better in ovarian cancer
MedPage Today
Shortening the time between chemotherapy sessions improved quality of life in women with advanced ovarian cancer without affecting efficacy. In a randomized phase III trial, dubbed MITO-7, weekly chemotherapy with a standard drug combination also had significantly less toxicity than the usual program of sessions every three weeks.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study: Genetic testing uptake within cancer-affected families remains low
Genetic Engineering & Biotechnology News
Though it can point to options for individuals to manage their cancer risk, take-up of genetic testing for cancer-causing mutations in affected families in France remains very low, Montpellier University Hospital's Pascal Pujol, MD, PhD, has found.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Gain Insight. Maximize Profit.

MediGain has analyzed the top physicians offices around the country and compiled the Top 10 Metrics they use to maximize their practice's revenue. You can't manage what you can't measure. Here are 10 metrics that you can track so you can spend more time providing quality health care for your patients. Plus, you will end up with more cash at the end of the day/month/year.
 


Sorafenib slows progression in advanced thyroid cancer
CancerNetwork
At the 2013 meeting of the American Society of Clinical Oncology, there were promising results for patients with metastatic differentiated thyroid cancer refractory to standard treatment with radioactive iodine. Investigators from the international randomized phase III DECISION trial found treatment with the multitargeted tyrosine kinase inhibitor sorafenib, which inhibits tumor growth signaling and angiogenesis, delayed disease progression by five months in patients with metastatic DTC that had progressed on RAI therapy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Women can be screened for colorectal cancer later than men undergoing 'virtual colonoscopy'
News Medical
A new study has found that women can be screened for colorectal cancer at least five to 10 years later than men when undergoing an initial "virtual colonoscopy." Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may help establish guidelines for the use of this screening technique, which is less invasive than a traditional colonoscopy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Oncology OnTrack Supports Nurse Navigation
Oncology OnTrack is used to navigate patients with any cancer type from screening to diagnosis, treatment and survivorship, interfaces with other programs and supports accreditations.
Advertise here!

To find out how to feature your company in The CoC Brief and other advertising opportunities, contact James DeBois at 469-420-2618.
MORE


Inhalation therapy for lung cancer shows promise
Health Canal
Lung cancer kills about 1.5 million men and women around the world — more than the number of people who die from breast, colon, pancreatic and prostate cancers combined. Animal studies indicate that delivering chemotherapy through inhalation kills more cancer cells than traditional intravenous chemotherapy. The next step: clinical trials in humans.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA blasts Aveo 1 last time for 'uninterpretable' cancer study
Fierce BioTech
The other shoe has dropped at Aveo Oncology. Days after the Cambridge, MA-based biotech whacked close to two-thirds of its staff as it scrambled to stay afloat in the wake of a scathing regulatory assessment of its lead drug, the developer says that the FDA has handed over the expected rejection notice for tivozanib as a treatment for kidney cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The weird world of colonoscopy costs
The New York Times
Colonoscopies are one of three standard ways to screen for colorectal cancer. So it is disturbing to learn that the cost of this routine procedure, performed on more than 10 million Americans each year, differs radically from state to state and even within the same metropolitan area.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword THYROID CANCER.


Shape-shifting cells help skin cancer spread
Medical Xpress
Scientists have discovered genes that control shape changes in melanoma skin cancer cells, allowing them to wriggle free and spread around the body, according to new research published in Nature Cell Biology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Sequester hits cancer patients — doctors, lawmakers seek fix
Yahoo! News
After Congress failed to pass a budget this spring, a 2 percent cut to Medicare chemotherapy drug reimbursements went into effect April 1 as part of the across-the-board federal spending cuts designed to save $85.4 billion this year.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Blood test may detect colon cancer, early research suggests
NBC News
Most people would rather deliver a speech naked than get a colonoscopy (and some would argue there's not much difference). New research indicates many people may one day be able to avoid the uncomfortable procedure with a simple, noninvasive and reliable test for colon cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 




The CoC Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Andrew Plock, Content Editor, 469.420.2609  
Contribute news

Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

June 5, 2013
May 29, 2013
May 22, 2013
May 15, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063